학술논문
OA03.08 Trilaciclib Reduces the Need for Growth Factors and Red Blood Cell Transfusions to Manage Chemotherapy-Induced Myelosuppression
Document Type
Abstract
Author
Source
In Journal of Thoracic Oncology January 2021 16(1) Supplement:S4-S4
Subject
Language
ISSN
1556-0864